Attached files

file filename
EX-32.2 - EX-32.2 - HEAT BIOLOGICS, INC.htbx-20210630xex32d2.htm
EX-31.2 - EX-31.2 - HEAT BIOLOGICS, INC.htbx-20210630xex31d2.htm
EX-31.1 - EX-31.1 - HEAT BIOLOGICS, INC.htbx-20210630xex31d1.htm
EX-10.5 - EX-10.5 - HEAT BIOLOGICS, INC.htbx-20210630xex10d5.htm
EX-10.4 - EX-10.4 - HEAT BIOLOGICS, INC.htbx-20210630xex10d4.htm
EX-10.3 - EX-10.3 - HEAT BIOLOGICS, INC.htbx-20210630xex10d3.htm
EX-10.2 - EX-10.2 - HEAT BIOLOGICS, INC.htbx-20210630xex10d2.htm
10-Q - 10-Q - HEAT BIOLOGICS, INC.htbx-20210630x10q.htm

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Heat Biologics, Inc. (the “Registrant”) hereby certifies, to such officer’s knowledge, that:

(1)

the accompanying Quarterly Report on Form 10-Q of the Registrant for the quarter ended June 30, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Date: August 11, 2021

By:

/s/ Jeffrey Wolf

 

 

Name: Jeffrey Wolf

 

 

Title: Chief Executive Officer

 

 

(Principal Executive Officer)